Francisco Javier Munguia-Galaviz
Overview
Explore the profile of Francisco Javier Munguia-Galaviz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munguia-Galaviz F, Miranda-Diaz A, Gutierrez-Mercado Y, Ku-Centurion M, Gonzalez-Gonzalez R, Portilla-de Buen E, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200372
The Sigma-1 Receptor (Sigmar1) is a stress-activated chaperone and a promising target for pharmacological modulation due to its ability to induce multiple cellular responses. Yet, it is unknown how Sigmar1...
2.
Munguia-Galaviz F, Gutierrez-Mercado Y, Miranda-Diaz A, Portilla de Buen E, Flores-Soto M, Echavarria R
Heliyon
. 2024 Mar;
10(6):e27468.
PMID: 38509984
Background: Cardiorenal syndrome (CRS) type 4 is prevalent among the chronic kidney disease (CKD) population, with many patients dying from cardiovascular complications. However, limited data regarding cardiac transcriptional changes induced...
3.
Munguia-Galaviz F, Miranda-Diaz A, Cardenas-Sosa M, Echavarria R
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36768323
Cardiovascular and renal diseases are among the leading causes of death worldwide, and regardless of current efforts, there is a demanding need for therapeutic alternatives to reduce their progression to...
4.
Andrade-Sierra J, Pazarin-Villasenor L, Yanowsky-Escatell F, Diaz-de la Cruz E, Garcia-Sanchez A, Cardona-Munoz E, et al.
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36232497
Early Chronic Kidney Disease (CKD) is a condition that tends to progress to End-Stage Kidney Disease (ESKD). Early diagnosis of kidney disease in the early stages can reduce complications. Alterations...
5.
Salazar-Gonzalez H, Gutierrez-Mercado Y, Munguia-Galaviz F, Echavarria R
J Cardiovasc Dev Dis
. 2022 May;
9(5).
PMID: 35621843
Myocardial damage in acute myocardial infarctions (AMI) is primarily the result of ischemia−reperfusion injury (IRI). Recognizing the timing of transcriptional events and their modulation by cardioprotective strategies is critical to...